LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | R406 | 0.04 | uM | LJP6 | 72 | hr | 962 | 10120 | 10605 | 0.9543 | 0.9497 |
MCF 10A | Pictilisib | 0.04 | uM | LJP6 | 72 | hr | 962 | 10649 | 10605 | 1.0041 | 1.0046 |
MCF 10A | Gefitinib | 0.04 | uM | LJP6 | 72 | hr | 962 | 9196 | 10605 | 0.8671 | 0.8539 |
MCF 10A | Geldanamycin | 0.04 | uM | LJP5 | 72 | hr | 962 | 1729 | 10605 | 0.1630 | 0.0795 |
MCF 10A | Geldanamycin | 0.04 | uM | LJP6 | 72 | hr | 962 | 1229 | 10605 | 0.1159 | 0.0277 |
MCF 10A | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 962 | 10852 | 10605 | 1.0233 | 1.0256 |
MCF 10A | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 962 | 10758 | 10605 | 1.0144 | 1.0159 |
MCF 10A | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 962 | 9104 | 10605 | 0.8585 | 0.8444 |
MCF 10A | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 962 | 1009 | 10605 | 0.0951 | 0.0049 |
MCF 10A | GSK 690693 | 0.04 | uM | LJP5 | 72 | hr | 962 | 10482 | 10605 | 0.9884 | 0.9873 |
MCF 10A | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 962 | 9967 | 10605 | 0.9399 | 0.9339 |
MCF 10A | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 962 | 10133 | 10605 | 0.9555 | 0.9510 |
MCF 10A | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 962 | 10682 | 10605 | 1.0073 | 1.0080 |
MCF 10A | Imatinib | 0.04 | uM | LJP6 | 72 | hr | 962 | 10713 | 10605 | 1.0102 | 1.0113 |
MCF 10A | JNK-9L | 0.04 | uM | LJP6 | 72 | hr | 962 | 10851 | 10605 | 1.0232 | 1.0255 |
MCF 10A | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 962 | 10930 | 10605 | 1.0307 | 1.0338 |
MCF 10A | Lapatinib | 0.04 | uM | LJP6 | 72 | hr | 962 | 10747 | 10605 | 1.0134 | 1.0148 |
MCF 10A | LDN-193189 | 0.04 | uM | LJP5 | 72 | hr | 962 | 10223 | 10605 | 0.9640 | 0.9604 |
MCF 10A | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 962 | 11413 | 10605 | 1.0762 | 1.0839 |
MCF 10A | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 10729 | 10605 | 1.0117 | 1.0129 |
MCF 10A | Mitoxantrone | 0.04 | uM | LJP5 | 72 | hr | 962 | 2239 | 10605 | 0.2111 | 0.1324 |
MCF 10A | Mitoxantrone | 0.04 | uM | LJP6 | 72 | hr | 962 | 2046 | 10605 | 0.1930 | 0.1125 |
MCF 10A | MK2206 | 0.04 | uM | LJP6 | 72 | hr | 962 | 9755 | 10605 | 0.9198 | 0.9118 |
MCF 10A | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 4873 | 10605 | 0.4595 | 0.4056 |
MCF 10A | Nilotinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 9781 | 10605 | 0.9224 | 0.9146 |